Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Teratogenic drugs — part 1

Teratogenic drugs — part 1 The risks and benefits of drug therapy in pregnancy remain difficult to evaluate. This article, in two parts, sets out some general principles of teratogenesis and prescribing in pregnancy, lists drugs known to be fetotoxic or teratogenic, and describes the specific problems that occur with drugs acting on the central nervous system. These include facial dysmorphism and neural tube defects with anticonvulsant drugs; potential cardiac defects with lithium; and possible withdrawal syndromes with antidepressant drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Adverse Drug Reaction Bulletin Wolters Kluwer Health

Teratogenic drugs — part 1

McElhatton, Patricia
Adverse Drug Reaction Bulletin , Volume &NA; (213) – Apr 1, 2002
Download PDF
4 pages

Loading next page...
 
/lp/wolters-kluwer-health/teratogenic-drugs-mdash-part-1-y0VIOj09xp

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 2002 Lippincott Williams & Wilkins
ISSN
0044-6394
eISSN
2159-7774

Abstract

The risks and benefits of drug therapy in pregnancy remain difficult to evaluate. This article, in two parts, sets out some general principles of teratogenesis and prescribing in pregnancy, lists drugs known to be fetotoxic or teratogenic, and describes the specific problems that occur with drugs acting on the central nervous system. These include facial dysmorphism and neural tube defects with anticonvulsant drugs; potential cardiac defects with lithium; and possible withdrawal syndromes with antidepressant drugs.

Journal

Adverse Drug Reaction Bulletin – Wolters Kluwer Health

Published: Apr 1, 2002

There are no references for this article.